
Academic Journal
Q1Journal of Immunotherapy
About Journal of Immunotherapy
Journal of Immunotherapy is a scholarly journal published by Lippincott Williams and Wilkins. SCImago 2025 lists it in Q1, with an SJR of 1.088 and H-index of 111.
Coverage: 1991-2026. Research categories: Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2); Immunology and Allergy (Q2).
Source-backed journal facts
Topics in published research
Immunotherapy and Immune Responses; CAR-T cell therapy research; Cancer Immunotherapy and Biomarkers; Immune Cell Function and Interaction; Monoclonal and Polyclonal Antibodies Research; T-cell and B-cell Immunology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Clinical Features, Treatment, and Outcomes of Sintilimab-induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Zhaoquan Wu, Yong Pan, Miao Liu, Wei Sun et al.
2026-09-21 · DOI: 10.1097/cji.0000000000000622Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing
Mohammadamin Sookhaklari, Adnan Moinuddin, Kanwaldeep Singh, M. Talha Yuksel et al.
2026-09-14 · DOI: 10.1097/cji.0000000000000618Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for Glioblastoma
Ali Anvarian, Fatemeh S.M. Nazari, Ali Karimi Jashni
2026-08-27 · DOI: 10.1097/cji.0000000000000617Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: Clinical Presentation and Outcomes in Three Patients
Mayte G. Martinez-Garza, Effrosyni Apostolidou, Hugo R. Lara-Martinez, Thein H. Oo et al.
2026-10 · DOI: 10.1097/cji.0000000000000614IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway
Wei Chen
2026-10 · DOI: 10.1097/cji.0000000000000613Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study
Nazım C. Demircan, Melek Özdemir, Sevinç Ballı, Naziyet Köse Baytemur et al.
2026-10 · DOI: 10.1097/cji.0000000000000610Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor–Induced Adrenal Insufficiency: A Case Report
Nila N. Sabetfakhri, Hibba Tul Rehman, Deborah L. Cook, Kaitlyn V. Barrett et al.
2026-10 · DOI: 10.1097/cji.0000000000000609Dual Roles of EZH2 in Tumor Proliferation and Immune Evasion in Lung Squamous Cell Carcinoma: A Pathway to Novel Immunotherapeutic Approaches
Ling Xu, Chun Ye, Shuihong Yu
2025-07 · DOI: 10.1097/cji.0000000000000560Identification of Immune Characteristics of 2 Subtypes of Breast Cancer by Combining Polyamine Metabolism-related Genes to Help With Immunotherapy
Xiuwen Yi, Bin Tang, Qinghua Mo, Yulan Tang et al.
2025-07 · DOI: 10.1097/cji.0000000000000559Immune Profiling of Uveal Melanoma Liver Metastases and Response to Checkpoint Inhibitors
Yusra F. Shao, Yasmine Baca, Andrew Hinton, Joanne Xiu et al.
2025-06 · DOI: 10.1097/cji.0000000000000558Effects of Antibiotics on First-line Immunotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Yuting Fang, Binhao Wu, Rong Zhang, Xiaozhong Chen et al.
2025-07 · DOI: 10.1097/cji.0000000000000556Integrative Multi-Omics Analysis Reveals Molecular Subtypes of Ovarian Cancer and Constructs Prognostic Models
Min Zhou, Jie Pi, Yuzi Zhao
2025-07 · DOI: 10.1097/cji.0000000000000557Combined CLEC2d Expression and CD58 Loss Mitigate Rejection of Allogeneic T Cells
Lindsey J. Coholan, Cisem Karaca, Faith M. Musenge, Moriah L. White et al.
2025-05 · DOI: 10.1097/cji.0000000000000552Identification of Endoplasmic Reticulum Stress-related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Sensitivity in Thyroid Cancer
Lu Zhao, Shuangmei Zhu, Wenxia Ye, Lifen Chen et al.
2025-06 · DOI: 10.1097/cji.0000000000000554Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels
Yuma Shibutani, Atsushi Kawanobe, Shinya Suzuki, Takuro Imaoka et al.
2025-06 · DOI: 10.1097/cji.0000000000000555High Expression of Calreticulin Affected the Tumor Microenvironment and Correlated With Worse Prognosis in Patients With Triple-Negative Breast Cancer
Xi Cao, Xinyu Ren, Yu Song, Qiang Sun et al.
2025-06 · DOI: 10.1097/cji.0000000000000553RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer
Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, Chieri Nakayama et al.
2025-05 · DOI: 10.1097/cji.0000000000000550The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study
Sze Wah Samuel Chan, Gregory R. Pond, John R. Goffin
2025-05 · DOI: 10.1097/cji.0000000000000551Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma
Yasser Ged, Amina Touma, Luis Meza Contreras, Roy Elias et al.
2025-04 · DOI: 10.1097/cji.0000000000000549Secondary Hemophagocytic Lymphohistiocytosis Syndrome Developing in a Patient With Chronic Lymphocytic Leukemia Under a Long-term Ibrutinib Therapy: A Case Report and Literature Review
Liang Gao, Lihong Wang, Bingjie Wang, Qian Wang et al.
2025-04 · DOI: 10.1097/cji.0000000000000547Reviews
Community Reviews
Version History
October 4, 2026 at 8:57 pm
September 25, 2026